News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
306,460 Results
Type
Article (17298)
Company Profile (282)
Press Release (288880)
Multimedia
Podcasts (51)
Webinars (8)
Section
Business (93960)
Career Advice (472)
Deals (15471)
Drug Delivery (38)
Drug Development (52579)
Employer Resources (52)
FDA (6630)
Job Trends (6015)
News (163974)
Policy (11518)
Tag
Academia (1088)
Accelerated approval (4)
Adcomms (12)
Allergies (59)
Alliances (23824)
ALS (65)
Alzheimer's disease (911)
Antibody-drug conjugate (ADC) (105)
Approvals (6654)
Artificial intelligence (146)
Autoimmune disease (19)
Automation (9)
Bankruptcy (112)
Best Places to Work (5262)
BIOSECURE Act (9)
Biosimilars (58)
Biotechnology (233)
Bladder cancer (63)
Brain cancer (21)
Breast cancer (157)
Cancer (1543)
Cardiovascular disease (128)
Career advice (399)
Career pathing (11)
CAR-T (119)
Cell therapy (343)
Cervical cancer (9)
Clinical research (42811)
Collaboration (593)
Compensation (259)
Complete response letters (14)
COVID-19 (1148)
CRISPR (42)
C-suite (168)
Cystic fibrosis (78)
Data (1586)
Denatured (13)
Depression (33)
Diabetes (155)
Diagnostics (1870)
Digital health (4)
Diversity (4)
Diversity, equity & inclusion (16)
Drug discovery (90)
Drug pricing (33)
Drug shortages (5)
Duchenne muscular dystrophy (91)
Earnings (39967)
Editorial (19)
Employer branding (8)
Employer resources (46)
Events (51323)
Executive appointments (487)
FDA (7381)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (518)
Gene editing (97)
Generative AI (13)
Gene therapy (266)
GLP-1 (417)
Government (1293)
Grass and pollen (3)
Guidances (35)
Healthcare (7739)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (97)
Indications (21)
Infectious disease (1220)
Inflammatory bowel disease (115)
Inflation Reduction Act (8)
Influenza (24)
Intellectual property (69)
Interviews (83)
IPO (8497)
IRA (15)
Job creations (1059)
Job search strategy (354)
Kidney cancer (7)
Labor market (10)
Layoffs (240)
Leadership (10)
Legal (1717)
Liver cancer (36)
Lung cancer (214)
Lymphoma (106)
Machine learning (4)
Management (14)
Manufacturing (154)
MASH (53)
Medical device (3846)
Medtech (3848)
Mergers & acquisitions (7341)
Metabolic disorders (434)
Multiple sclerosis (58)
NASH (13)
Neurodegenerative disease (70)
Neuropsychiatric disorders (25)
Neuroscience (1336)
NextGen: Class of 2025 (2547)
Non-profit (1138)
Now hiring (23)
Obesity (221)
Opinion (138)
Ovarian cancer (63)
Pain (44)
Pancreatic cancer (58)
Parkinson's disease (122)
Partnered (11)
Patents (140)
Patient recruitment (83)
Peanut (40)
People (27463)
Pharmaceutical (47)
Pharmacy benefit managers (6)
Phase I (14873)
Phase II (19785)
Phase III (12816)
Pipeline (931)
Policy (56)
Postmarket research (1001)
Preclinical (6275)
Press Release (30)
Prostate cancer (71)
Psychedelics (37)
Radiopharmaceuticals (215)
Rare diseases (300)
Real estate (1623)
Recruiting (20)
Regulatory (9672)
Reports (19)
Research institute (1064)
Resumes & cover letters (65)
Rett syndrome (4)
RNA editing (5)
RSV (11)
Schizophrenia (61)
Series A (99)
Series B (67)
Service/supplier (1)
Sickle cell disease (40)
Special edition (11)
Spinal muscular atrophy (124)
Sponsored (19)
Startups (2097)
State (1)
Stomach cancer (6)
Supply chain (28)
Tariffs (12)
The Weekly (37)
Vaccines (240)
Venture capitalists (33)
Weight loss (133)
Women's health (18)
Worklife (4)
Date
Today (110)
Last 7 days (555)
Last 30 days (1628)
Last 365 days (21156)
2025 (6833)
2024 (22307)
2023 (24522)
2022 (30880)
2021 (31675)
2020 (26943)
2019 (19419)
2018 (14191)
2017 (15510)
2016 (13434)
2015 (16225)
2014 (11763)
2013 (8469)
2012 (8777)
2011 (8915)
2010 (8611)
Location
Africa (241)
Alabama (43)
Alaska (3)
Arizona (60)
Arkansas (5)
Asia (19284)
Australia (3370)
California (4093)
Canada (1228)
China (373)
Colorado (159)
Connecticut (166)
Delaware (103)
Europe (42121)
Florida (541)
Georgia (122)
Idaho (22)
Illinois (263)
India (11)
Indiana (120)
Iowa (3)
Japan (80)
Kansas (62)
Kentucky (6)
Louisiana (8)
Maine (17)
Maryland (507)
Massachusetts (3226)
Michigan (90)
Minnesota (165)
Mississippi (1)
Missouri (29)
Montana (18)
Nebraska (9)
Nevada (20)
New Hampshire (25)
New Jersey (1060)
New Mexico (14)
New York (1137)
North Carolina (613)
North Dakota (5)
Northern California (1815)
Ohio (119)
Oklahoma (9)
Oregon (21)
Pennsylvania (812)
Puerto Rico (7)
Rhode Island (19)
South America (328)
South Carolina (5)
South Dakota (1)
Southern California (1564)
Tennessee (36)
Texas (487)
United States (14364)
Utah (74)
Virginia (87)
Washington D.C. (32)
Washington State (377)
Wisconsin (19)
306,460 Results for "gain therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gain Therapeutics Announces Poster Presentation at AD/PD 2025
March 31, 2025
·
4 min read
Press Releases
Gain Therapeutics Announces Oral Presentation at AD/PD 2025
March 7, 2025
·
5 min read
Press Releases
Gain Therapeutics To Participate in Upcoming Investor Conferences
February 5, 2025
·
3 min read
Press Releases
Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
April 30, 2025
·
5 min read
Press Releases
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2024 and Provides Corporate Update
March 28, 2025
·
10 min read
Business
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
Gain Therapeutics, Inc. announces that Matthias Alder has departed the Company in order to pursue other opportunities.
June 27, 2024
·
5 min read
Press Releases
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease
March 17, 2025
·
5 min read
Press Releases
Gain Therapeutics Presents Additional Preclinical Data and Design of Phase 1b Clinical Study of GT-02287 at AD/PD 2025 and Provides Enrollment Update
April 10, 2025
·
9 min read
Press Releases
Gain Therapeutics CEO Gene Mack Issues Letter To Shareholders and Provides Operational Update
February 6, 2025
·
9 min read
Press Releases
Gain Therapeutics To Present At Biotech Showcase 2025
December 11, 2024
·
4 min read
1 of 30,646
Next
